FDA Grants Fast Track Status to Amplyx Pharmaceuticals for IV and Oral Formulations of Fosmanogepix (APX001) for Seven Different Indications
https://www.prnewswire.com/news-releases/fda-grants-fast-track-status-to-amplyx-pharmaceuticals-for-iv-and-oral-formulations-of-fosmanogepix-apx001-for-seven-different-indications-300913746.htmlWe Desperately Need to Develop New Antifungals
https://www.labiotech.eu/medical/new-antifungals-development/